Brendan O’Grady

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

Company

Current role

CEO, Board Member

2024-01-01–present

5 calls Latest call 2025-08-11

AMWL

Current role

Board Member

2015-01-01–present

TEVA

Current role

Board Member

2017-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	—	CEO	$721,933	—	$405,900	$547,529	—	$209,622	$1,884,984
2024	—	CEO	$502,372	—	$495,000	$1,587,420	$406,949	$20,962	$3,012,703
2021	American Well Corp (AMWL)	Chief Commercial and Growth Officer	$181,875	—	$8,185,030	—	$485,000	$37,875	$8,889,780
2020	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, NorthAmerica Commercial	$776,923	$0	$2,299,991	$0	$991,198	$58,171	$4,126,283
2019	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, NorthAmerica Commercial	$676,923	$20,500	$1,899,988	$0	$800,868	$64,011	$3,462,290

Earnings-call appearances and filed executive appointments or departures, newest first.